Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

revogene

K-Number: K170558 · 2017-05-25

ApplicantGenepoc, Inc.
Decision Date2017-05-25
Product CodeOOI
Advisory CommitteeCH
DecisionSubstantially Equivalent

Device Summary

revogene is the device name listed in this FDA 510(k) record. The listed applicant is Genepoc, Inc.. It received FDA 510(k) clearance on 2017-05-25 under 510(k) number K170558. The device is classified under product code OOI. It was reviewed by the CH advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the revogene?

revogene is a medical device that received FDA 510(k) clearance on 2017-05-25. The listed applicant is Genepoc, Inc.. The 510(k) number is K170558.

When did revogene receive FDA 510(k) clearance?

revogene received FDA 510(k) clearance on 2017-05-25, under 510(k) number K170558.

Who is the listed applicant for revogene?

The FDA 510(k) record lists Genepoc, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for revogene?

The FDA product code for revogene is OOI.

Other records listing Genepoc, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: OOI)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.